NSC |
Compound |
Enrichment |
Correlation |
NSC 741940 |
Null |
0.00163653239752571 |
0.50097367 |
NSC 742554 |
7H-Furo[3,2-g][1]benzopyran-7-one, 4-[[(2E)-5-[4'-[[(2E)-6,7-dihydroxy-3,7-dimethyl-2-octenyl]oxy]-5,5-dimethyl-spiro[1,3-dioxolane-2,7'-[7H]furo[3,2-g][1]benzopyran]-4-yl]-3-methyl-2-pentenyl]oxy]-, |
0.00163653239752571 |
0.16328746 |
NSC 756188 |
GSK718429A |
0.00163653239752571 |
0.46275683 |
NSC 760476 |
5,6,7,8-tetrafluoronaphtho[2,3-c][1,2,5]thiadiazole-4,9-dione |
0.00163653239752571 |
0.23545039 |
NSC 87221 |
Actinomycin D, 2A-D-alloisoleucine- (9CI) |
0.00163653239752571 |
0.2149555 |
NSC 98904 |
Thiazolo[3,2-f]phenanthridinium, 3-phenyl- perchlorate |
0.00163653239752571 |
0.20758412 |
NSC 129794 |
Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) |
0.00163653239752573 |
0.34343948 |
NSC 13151 |
Null |
0.00163653239752573 |
0.53298837 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.00163653239752573 |
0.48570655 |
NSC 372155 |
2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- |
0.00163653239752573 |
0.057115789 |